Literature DB >> 4199744

Trial of chloramphenicol for meningitis in northern savanna of Africa.

H C Whittle, N M Davidson, B M Greenwood, D A Warrell, A Tomkins, P Tugwell, A Zalin, A D Bryceson, E H Parry, M Brueton, M Duggan, A D Rajković.   

Abstract

In a controlled trial chloramphenicol proved as effective and much cheaper than penicillin for the treatment of group A meningococcal meningitis in Zaria, Nigeria. A short course of five days cured most patients. Adults and older children were soon able to take chloramphenicol by mouth, which reduced the cost and simplified treatment.It is suggested that chloramphenicol is a suitable alternative to sulphonamides for the treatment of meningococcal meningitis in those parts of Africa where the organism is sulphonamide-resistant.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4199744      PMCID: PMC1586699          DOI: 10.1136/bmj.3.5876.379

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  CHANGING SUSCEPTIBILITY OF MENINGOCOCCI TO ANTIMICROBIAL AGENTS.

Authors:  T C EICKHOFF; M FINLAND
Journal:  N Engl J Med       Date:  1965-02-25       Impact factor: 91.245

2.  Therapeutic range of chloramphenicol in purulent meningitis.

Authors:  R T PARKER; M J SNYDER; R S LIU; J W LOOPER; T E WOODWARD
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1955-04

3.  Treatment of meningitis with chloromycetin palmitate; results of therapy in twenty-three cases.

Authors:  G E DEANE; J E FURMAN; A R BENTZ; T E WOODWARD
Journal:  Pediatrics       Date:  1953-04       Impact factor: 7.124

4.  Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections.

Authors:  B M Greenwood; H C Whittle; O Dominic-Rajkovic
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

5.  Efficacy of intramuscular chloramphenicol in treatment of H. influenzae meningitis.

Authors:  N K Bulos
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

6.  General review of the treatment of meningitis.

Authors:  K Sorensen
Journal:  J Egypt Public Health Assoc       Date:  1969

7.  Statewide study of chloramphenicol therapy and fatal aplastic anemia.

Authors:  R O Wallerstein; P K Condit; C K Kasper; J W Brown; F R Morrison
Journal:  JAMA       Date:  1969-06-16       Impact factor: 56.272

8.  Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and rocky mountain spotted fever.

Authors:  H L DuPont; R B Hornick; C F Weiss; M J Snyder; T E Woodward
Journal:  N Engl J Med       Date:  1970-01-08       Impact factor: 91.245

9.  Sulfa-drug resistance and serologic studies of a meningococcal meningitis epidemic.

Authors:  W R Sanborn
Journal:  J Egypt Public Health Assoc       Date:  1969

10.  [Biological and clinical data concerning the reaction of Neisseria meningitides A to several sulfonamides and antibiotics: observations at Fort-Lamy (Chad) during a seasonal outbreak of cerebrospinal meningitis].

Authors:  M Lefèvre; J Sirol; M Vandekerkove; R Faucon
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  10 in total
  5 in total

Review 1.  Bacterial meningitis. Some aspects of diagnosis and treatment.

Authors:  G Hambleton; P A Davies
Journal:  Arch Dis Child       Date:  1975-09       Impact factor: 3.791

2.  Sulbactam/ampicillin in the treatment of epidemic meningococcal meningitis in northern Nigeria.

Authors:  A I Dutse; Y M Fakunle; G O Oyeyinka; C S Bello
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Epidemic group C meningococcal meningitis in Upper Volta, 1979.

Authors:  C V Broome; M A Rugh; A A Yada; L Giat; H Giat; J M Zeltner; W R Sanborn; D W Fraser
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

4.  Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden.

Authors:  M A Salih; D Danielsson; A Bäckman; D A Caugant; M Achtman; P Olcén
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

Review 5.  Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.